azole resistance has emerged as a global health problem. We evaluated the antifungal susceptibility of 221 clinical isolates according to CLSI guidelines. Sixty-one isolates exhibiting MICs at the epidemiological cutoff value (ECV) for itraconazole or above the ECV for any triazole were checked for mutations.
View Article and Find Full Text PDF